Actively replicating West Nile virus is resistant to cytoplasmic delivery of siRNA
<p>Abstract</p> <p>Background</p> <p>West Nile virus is an emerging human pathogen for which specific antiviral therapy has not been developed. Recent studies have suggested that RNA interference (RNAi) has therapeutic potential as a sequence specific inhibitor of viral...
Main Authors: | Diamond Michael S, Pierson Theodore C, Geiss Brian J |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-06-01
|
Series: | Virology Journal |
Online Access: | http://www.virologyj.com/content/2/1/53 |
Similar Items
-
Cytoplasmic delivery of siRNA using human-derived membrane penetration-enhancing peptide
by: Momoko Nakamura, et al.
Published: (2022-10-01) -
Dendrimers for siRNA Delivery
by: Swati Biswas, et al.
Published: (2013-02-01) -
Drug Delivery of siRNA Therapeutics
by: Gaetano Lamberti, et al.
Published: (2020-02-01) -
Recent advances in siRNA delivery
by: Sarisozen Can, et al.
Published: (2015-12-01) -
Lipid-Based Formulations for siRNA Delivery
by: Foged, C, et al.
Published: (2009)